19 April,2018 01:52 PM IST | Washington | ANI
Representational picture
A new protein has been found that is associated with breast cancer patients' survival. According to a study conducted by the UT Southwestern Medical Center, this protein is strongly associated with metastatic breast cancer and that could be a target for future therapies.
High levels of the protein ZMYND8 are correlated with poor survival in breast cancer patients, said researcher Weibo Luo. Previous research has shown that breast cancer cells are more aggressive in an oxygen-deprived, or hypoxic, environment. A protein family called hypoxia-inducible factor (HIF) controls responses to hypoxia, switching on pathways that lead to cancer cell growth and spread.
"Our research shows that ZMYND8 is a regulator that activates hundreds of HIF-dependent oncogenes in breast cancer cells," Luo said. "Our studies uncovered a feedback loop that amplifies HIF-controlled oncogenes to drive breast tumor malignancy," said researcher Yingfei Wang.
ALSO READ
Horoscope today, Nov 25: Check astrological predictions for all zodiac signs
Bigg Boss 18: Top 2 contender Alice Kaushik evicted; Hina Khan gets emotional
J-K's Sher-e-Kashmir hospital to get LINAC for cancer treatment
'Unproven remedies': Tata Memorial Hospital slams Sidhu’s viral cancer claim
Weekly horoscope: Check astrological predictions for all zodiac signs
Approximately 250,000 women were diagnosed with breast cancer in 2017, according to National Institutes of Health figures, and about 40,000 died of the disease. Metastatic breast cancer is cancer that has spread to other sites in the body, and the vast majority of breast cancer deaths occur in patients in whom cancer has metastasised.
"This work uncovers a primary epigenetic mechanism of HIF-mediated breast cancer progression, and reveals a possible molecular target for diagnosis and treatment of aggressive disease," Luo said. The research appears in the Journal of Clinical Investigation.
Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever